Literature DB >> 17917102

Two cases of sarcoidosis-lymphoma syndrome.

Nada Suvajdzic1, Branislava Milenkovic, Maja Perunicic, Jelena Stojsic, Snezana Jankovic.   

Abstract

An association between sarcoidosis and lymphoproliferative diseases (LD), the sarcoidosis-lymphoma syndrome, has been previously described, and may be attributed to the underlying immunological abnormalities that occur during the sarcoidosis disease process. We report two patients who developed Hodgkin's disease and diffuse large B-cell non-Hodgkin's lymphoma (NHL) subsequent to their diagnosis of sarcoidosis after latency periods of 6 years and 18 years respectively. Both patients developed histologically-proven sarcoidosis late in life, at 46 years and 58 years, and had differing clinical courses. The first had radiographically staged II chronic progressive respiratory sarcoidosis (RS) and required long-term methotrexate to control the disease, while the second achieved a spontaneous remission of her stage I intrathoracic RS. After treatment, the patient with Hodgkin's disease remains in remission 2.5 years following six cycles of ABVD protocol chemotherapy and involved-field radiotherapy, while the NHL patient remains in remission at 3 years following six cycles of R-COP protocol chemotherapy. Clinicians should be aware of the potential risks of malignancy, and especially of LD in sarcoidosis patients. They should be alerted to the possibility of additional pathology by any atypical clinical features, and should biopsy new lesions and adenopathy to exclude any coexistent neoplasm.

Entities:  

Mesh:

Year:  2007        PMID: 17917102     DOI: 10.1007/s12032-007-0026-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  16 in total

1.  Muscle sarcoidosis following malignant lymphoma: diagnosis by MR imaging.

Authors:  Y Nakamura; N Kurihara; A Sato; M Nakamura; K Koyama; H Suzuki; H Saito; T Ishibashi; S Takahashi
Journal:  Skeletal Radiol       Date:  2002-06-26       Impact factor: 2.199

2.  Excess death of lung cancer among sarcoidosis patients.

Authors:  M Yamaguchi; M Odaka; Y Hosoda; K Iwai; T Tachibana
Journal:  Sarcoidosis       Date:  1991-03

Review 3.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

4.  Concurrent presentations of the sarcoidosis, tuberculosis and lymphoma in a single patient.

Authors:  Abdurrahman Tufan; Ortenca Ranci; Arzu Sungur; Arzu Topeli; Ibrahim Haznedaroglu; Lutfi Cöplü
Journal:  Respir Med       Date:  2005-10-19       Impact factor: 3.415

5.  Association between sarcoidosis and lymphoma revisited.

Authors:  M Karakantza; E Matutes; K MacLennan; N T O'Connor; P C Srivastava; D Catovsky
Journal:  J Clin Pathol       Date:  1996-03       Impact factor: 3.411

6.  Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.

Authors:  M Kornacker; A Kraemer; E Leo; A D Ho
Journal:  Ann Hematol       Date:  2002-01-10       Impact factor: 3.673

Review 7.  Sarcoid reactions in malignant tumours.

Authors:  H Brincker
Journal:  Cancer Treat Rev       Date:  1986-09       Impact factor: 12.111

Review 8.  Sarcoidosis following chemotherapy for Hodgkin's disease.

Authors:  T E Merchant; D A Filippa; J Yahalom
Journal:  Leuk Lymphoma       Date:  1994-04

9.  Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients.

Authors:  F K Rømer; P Hommelgaard; G Schou
Journal:  Eur Respir J       Date:  1998-10       Impact factor: 16.671

10.  The incidence of malignant tumours in patients with respiratory sarcoidosis.

Authors:  H Brincker; E Wilbek
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

View more
  5 in total

1.  A patient presenting with generalised lympadenopathy--sarcoidosis, lymphoma or tuberculosis?

Authors:  Nayia Petousi; Jovin Mathew; Enson C Thomas
Journal:  BMJ Case Rep       Date:  2012-02-25

2.  Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies.

Authors:  Lesley A Anderson; Shahinaz Gadalla; Lindsay M Morton; Ola Landgren; Ruth Pfeiffer; Joan L Warren; Sonja I Berndt; Winnie Ricker; Ruth Parsons; Eric A Engels
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

3.  Sarcoidosis and cutaneous lymphoma: What is the relationship?

Authors:  Vanessa Gargallo; Jéssica González Ramos; José Luis Rodríguez-Peralto; Concepción Postigo
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

4.  Sarcoidosis lymphoma syndrome - the value of PET-CT in the diagnosis.

Authors:  Adrian Kis; Noemi Eszes; Lilla Tamasi; Gyorgy Losonczy; Attila Csekeo; Judit Csomor; Veronika Muller
Journal:  World J Surg Oncol       Date:  2013-09-18       Impact factor: 2.754

5.  Sarcoidosis and Monoclonal Gammopathy of Undetermined Significance (MGUS): A True Association or Just a Coincidence?

Authors:  Mohamed Hassanein; Lilit Karapetyan; Afshan Khan; Supratik Rayamajhi
Journal:  Case Rep Hematol       Date:  2018-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.